| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |